ONE-WAYOngoing theme · still written in the latest filings
Post-approval adoption and overseas expansion of a fecal calprotectin assay
A theme focused on expanding adoption by medical institutions in Japan and clinical use overseas, mainly in Europe and the United States, following regulatory approval of a fecal calprotectin assay for assessing Crohn’s disease status.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.